TITLE

Frequent Transient Hepatitis C viremia without Seroconversion among Healthcare Workers in Cairo, Egypt

AUTHOR(S)
Munier, Aline; Marzouk, Diaa; Abravanel, Florence; El-Daly, Mai; Taylor, Sylvia; Mamdouh, Rasha; Eldin, Waleed Salah; El-Arab, Hanan Ezz; Sos, Dalia Gaber; Momen, Mohamed; Okasha, Omar; Le Fouler, Lenaig; El-Hosini, Mostafa; Izopet, Jacques; Rafik, Mona; Albert, Matthew; Abdel-Hamid, Mohamed; Mohamed, Mostafa Kamal; Delarocque-Astagneau, Elisabeth; Fontanet, Arnaud
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Backgrounds: With 10% of the general population aged 15–59 years chronically infected with hepatitis C virus (HCV), Egypt is the country with the highest HCV prevalence worldwide. Healthcare workers (HCWs) are therefore at particularly high risk of HCV infection. Our aim was to study HCV infection risk after occupational blood exposure among HCWs in Cairo. Methodology/Principal Findings: The study was conducted in 2008–2010 at Ain Shams University Hospital, Cairo. HCWs reporting an occupational blood exposure at screening, having neither anti-HCV antibodies (anti-HCV) nor HCV RNA, and exposed to a HCV RNA positive patient, were enrolled in a 6-month prospective cohort with follow-up visits at weeks 2, 4, 8, 12 and 24. During follow-up, anti-HCV, HCV RNA and ALT were tested. Among 597 HCWs who reported a blood exposure, anti-HCV prevalence at screening was 7.2%, not different from that of the general population of Cairo after age-standardization (11.6% and 10.4% respectively, p = 0.62). The proportion of HCV viremia among index patients was 37%. Of 73 HCWs exposed to HCV RNA from index patients, nine (12.3%; 95%CI, 5.8–22.1%) presented transient viremia, the majority of which occurred within the first two weeks after exposure. None of the workers presented seroconversion or elevation of ALT. Conclusions/Significance: HCWs of a general University hospital in Cairo were exposed to a highly viremic patient population. They experienced frequent occupational blood exposures, particularly in early stages of training. These exposures resulted in transient viremic episodes without established infection. These findings call for further investigation of potential immune protection against HCV persistence in this high risk group.
ACCESSION #
87625669

 

Related Articles

  • Hepatitis C Viremia Patterns in Incident Hepatitis C Infection and One Year Later in 150 Prospectively Tested Persons Who Inject Drugs. Alanko Blomé, Marianne; Björkman, Per; Molnegren, Vilma; Höglund, Peter; Widell, Anders // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Objectives: To assess HCV viremia levels just before, during and one year after anti-HCV seroconversion in people who inject drugs (PWID). Methods: PWID enrolling into a needle exchange program in Malmö, Sweden, 1997–2005 constituted the source population. Sera were obtained at...

  • TREATMENT OF HEPATITIS C IN DIALYSIS PATIENTS WITH PEGYLATED INTERFERON ALFA-2A - SINGLE DIALYSIS CENTER EXPERIENCE. Ćorić, Aida; Resić, Halima; Vukobrat-Bijedić, Zora; Avdić, Emir; Šahović, Vahidin; Mašnić, Fahrudin; Kukavica, Nihad // Medical Journal;oct-dec2011, Vol. 17 Issue 4, p304 

    Hepatitis C in dialysis patients is a "silent" nature of chronic infection that often can be the initial stage and go unnoticed. Start of viremic phase is usually associated with the activity of ALT (up to 70-74 U / L) and precedes seroconversion. This is followed by a constant viraemia, normal...

  • Occupational hepatitis C seroconversions in a Brazilian hospital. Medeiros, W. P.; Setúbal, S.; Pinheiro, P. Y. M.; Dalston, M. O.; Bazin, A. R.; de Oliveira, S. A. // Occupational Medicine;Dec2012, Vol. 62 Issue 8, p655 

    Background There are six known cases of occupational human immunodeficiency virus (HIV) seroconversion in Brazil. However, there are neither published cases of occupational hepatitis C virus (HCV) seroconversion nor systematic studies of blood and body fluid exposures (BBFE) that could estimate...

  • Gaziantep Ãœniversitesi Åžahinbey AraÅŸtırma ve Uygulama Hastanesi SaÄŸlık Çalışanlarında Hepatit B, Hepatit C ve HIV Seroprevalansı. BOŞNAK, Vuslat KEÇİK; KARAOĞLAN, İlkay; NAMIDURU, Mustafa; ŞAHİN, Ahmet // Viral Hepatitis Journal / Viral Hepatit Dergisi;Apr2013, Vol. 19 Issue 1, p11 

    Objective: Hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections, are an important health problem that threatens human health. Healthcare workers have an increased risk of being infected with a lot of pathogens. In this study it was aimed to...

  • Employee Hepatitis. Udell, Elliot // Podiatry Management;Feb2011, Vol. 30 Issue 2, p30 

    A letter to the editor is presented which is concerned with a podiatry office employee with hepatitis.

  • Pulmonary tuberculosis among health care workers at two designated DOTS Centers in urban city of Ibadan, Nigeria. Kehinde, A. O.; Baba, A.; Bakare, R. A.; Ige, O. M.; Gbadeyanka, C. F.; Adebiyi, O. E. // Indian Journal of Medical Research;Jun2011, Vol. 133 Issue 6, p613 

    Background & objectives: Tuberculosis (TB) infection control interventions are not routinely implemented in many Sub-Saharan African countries including Nigeria. This study was carried out to ascertain the magnitude of occupationally-acquired pulmonary TB (PTB) among health care workers (HCWs)...

  • Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment. Ogawa, Eiichi; Furusyo, Norihiro; Toyoda, Kazuhiro; Taniai, Hiroaki; Otaguro, Shigeru; Kainuma, Mosaburo; Murata, Masayuki; Sawayama, Yasunori; Hayashi, Jun // BMC Gastroenterology;2010, Vol. 10, p38 

    Background: An early virological response (EVR) after the start of interferon (IFN) treatment for chronic hepatitis C leads to a successful virological outcome. To analyze an association between sustained virological response (SVR) and EVR by comparing TaqMan with Amplicor assays in HCV genotype...

  • Interferon-alfa, interferon-λ and hepatitis C. O'Brien, Thomas R. // Nature Genetics;Oct2009, Vol. 41 Issue 10, p1048 

    Three new studies report genetic variants near IL28B, which encodes interferon-λ3 (interleukin 28B), are associated with response to treatment of chronic hepatitis C virus infection with interferon-alfa/ribavirin combination therapy. This renews interest in how interferons suppress viremia...

  • Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians. Mohammed, Reem; ElMakhzangy, Hesham Ibrahim; Gamal, Amira; Mekky, Fatma; El Kassas, Mohammed; Mohammed, Nabil; Hamid, Mohammed Abdel; Esmat, Gamal // Clinical Rheumatology;Dec2010, Vol. 29 Issue 12, p1373 

    Chronic hepatitis C virus (HCV) viremia has been known to provoke a plethora of autoimmune syndromes referred to as extrahepatic manifestations of chronic HCV infection. Aim of the current study was to assess the prevalence of rheumatologic manifestations among Egyptians with hepatitis C...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics